General MedicationsINJECTIONGeneric
DEPO-ESTRADIOL
ESTRADIOL CYPIONATE
Standard Dose
3MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DEPO-ESTRADIOL is listed in Drugs@FDA under application 085470 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTRADIOL CYPIONATE Form and strength INJECTABLE;INJECTION - 3MG/ML Sponsor PFIZER Submission history Latest submission status date: 2024-02-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview DEPO-ESTRADIOL is listed in Drugs@FDA under application 085470 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTRADIOL CYPIONATE Form and strength INJECTABLE;INJECTION - 3MG/ML Sponsor PFIZER Submission history Latest submission status date: 2024-02-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.